Mycobacterium arupense pulmonary infection: Antibiotic resistance and restriction fragment length polymorphism analysis

Indian Journal of Medical Microbiology

Volumn 28, Issue 2, 2010, Pages 173-176

  Neonakis, I K ^a   Gitti, Z ^a   Kontos, F ^b   Baritaki, S ^c   Petinaki, E ^d   Baritaki, M ^a   Liakou, V ^e   Zerva, L ^b   Spandidos, D A ^a,c  

^a UNIVERSITY HOSPITAL OF HERAKLION   (Greece)

^b NATIONAL AND KAPODISTRIAN UNIVERSITY OF ATHENS   (Greece)

^c UNIVERSITY OF CRETE   (Greece)

^d UNIVERSITY OF THESSALY   (Greece)

^e Venizelion General Hospital   (Greece)

Author keywords

Hsp65; Mycobacterium arupense; Non tuberculous mycobacteria

Indexed keywords

C REACTIVE PROTEIN; CLARITHROMYCIN; CREATININE; HEAT SHOCK PROTEIN 65; LEVOFLOXACIN; PIPERACILLIN PLUS TAZOBACTAM; RNA 16S;

ADULT; ANTIBIOTIC RESISTANCE; ARTICLE; ATELECTASIS; BACTERIUM COLONY; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATE; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; DNA ISOLATION; DYSPNEA; EPSILOMETER TEST; ERYTHROCYTE SEDIMENTATION RATE; HEMOPTYSIS; HUMAN; HYPERTENSION; INCUBATION TIME; KIDNEY MASS; LUNG INFECTION; LUNG INFILTRATE; LUNG PRESSURE; MALE; MEDIASTINUM LYMPH NODE; MINIMUM INHIBITORY CONCENTRATION; MITRAL VALVE DISEASE; MYCOBACTERIOSIS; MYCOBACTERIUM; MYCOBACTERIUM ARUPENSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PERICARDIAL EFFUSION; RECURRENT FEVER; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; RNA SEQUENCE; SPUTUM CULTURE; THORAX RADIOGRAPHY; TUBERCULOSIS;

EID: 77951742802     PISSN: 02550857     EISSN: 19983646     Source Type: Journal    
DOI: 10.4103/0255-0857.62502     Document Type: Article

References (12)

1. Neonakis IK, Gitti Z, Krambovitis E, Spandidos DA. Molecular diagnostic tools in mycobacteriology. J Microbiol Methods 2008;75:1-11.
2. Cloud JL, Meyer JJ, Pounder JI, Jost KC Jr, Sweeney A, Carroll KC, et al. Mycobacterium arupense sp. nov., a non-chromogenic bacterium isolated from clinical specimens. Int J Syst Evol Microbiol 2006;56:1413-1418
3. Masaki T, Ohkusu K, Hata H, Fujiwara N, Iihara H, Yamada-Noda M, et al. Mycobacterium kumamotonense Sp. Nov. recovered from clinical specimen and the first isolation report of Mycobacterium arupense in Japan: Novel slowly growing; nonchromogenic clinical isolates related to Mycobacterium terrae complex. Microbiol Immunol 2006;50:889-897
4. Tsai TF, Lai CC, Tsai IC, Chang CH, Hsiao CH, Hsueh PR. Tenosynovitis caused by Mycobacterium arupense in a patient with diabetes mellitus. Clin Infect Dis 2008;47:861-863
5. Koneman E, Allen S, Janda W, Schreckenberger P, Winn W. Colour atlas and textbook of Diagnostic Microbiology. Lippincott; Philadelphia, PA: 1997. p. 897-912.
6. Casas I, Klapper PE, Cleator GM, Echevarria JE, Tenorio A, Echevarria JM. Two different PCR assays to detect enteroviral RNA in CSF samples from patients with acute aseptic meningitis. J Med Virol 1995;47:378-385
7. Hiraishi A. Direct automated sequencing of 16SrDNA amplified by polymerase chain reaction from bacterial cultures without DNA purification. Lett Appl Microbiol 1992;15:210-213
8. Telenti A, Marchesi F, Balz M, Bally F, Bottger EC, Bodmer T. Rapid identification of mycobacteria to the species level by polymerase chain reaction and restriction enzyme analysis. J Clin Microbiol 1993;31:175-178
9. National Committee for Clinical Laboratory Standards. Performance standards for antimicrobial susceptibility testing. Thirteenth informational supplement, M100-S13. National Committee for Clinical Laboratory Standards, Villanova, PA, USA. 2003.
10. Lebrun L, Onody C, Vincent V, Nordmann P. Evaluation of the Etest for rapid susceptibility testing of Mycobacterium avium to clarithromycin. J Antimicrob Chemother 1996;37:999-1003.
11. Brown-Elliott BA, Crist CJ, Mann LB, Wilson RW, Wallace RJ Jr. In vitro activity of linezolid against slowly growing nontuberculous Mycobacteria. Antimicrob Agents Chemother 2003;47:1736-1738
12. American Thoracic Society. Diagnosis and treatment of disease caused by nontuberculous mycobacteria. Am J Respi Crit Care Med 1997;156:S1-25.